BIOMAT Database Logo BIOMAT Database Logo

Inhibition of erythrocyte membrane Ca(2+)-pumping ATPase of hypertensive humans by nifedipine, a calcium entry blocker. 1991

O O Olorunsogo, and O O Onatola, and S O Lawal, and E A Bababunmi, and A O Falase, and W G Okunade
Department of Biochemistry, College of Medicine, University of Ibadan, Nigeria.

Nifedipine, a 1,4-dihydropyridine antihypertensive drug, inhibited the basal activity of erythrocyte Ca2+,Mg(2+)-ATPase of hypertensive individuals in a concentration-dependent manner. About 50% inhibition was obtained at nifedipine concentrations greater than or equal to 300 microM. The extent of inhibition of the ATPase action was increased in the presence of calmodulin. Maximal inhibition at 400 microM was 76%. Furthermore, the activity of the partially trypsinized enzyme was inhibited by about 50% by 300 microM nifedipine. Similar results were obtained with membranes from normotensive individuals. These findings suggest that nifedipine could prevent Ca(2+)-pumping by the erythrocyte Ca2+,Mg(2+)-ATPase.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D009543 Nifedipine A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure. Adalat,BAY-a-1040,Bay-1040,Cordipin,Cordipine,Corinfar,Fenigidin,Korinfar,Nifangin,Nifedipine Monohydrochloride,Nifedipine-GTIS,Procardia,Procardia XL,Vascard,BAY a 1040,BAYa1040,Bay 1040,Bay1040,Monohydrochloride, Nifedipine,Nifedipine GTIS
D002121 Calcium Channel Blockers A class of drugs that act by selective inhibition of calcium influx through cellular membranes. Calcium Antagonists, Exogenous,Calcium Blockaders, Exogenous,Calcium Channel Antagonist,Calcium Channel Blocker,Calcium Channel Blocking Drug,Calcium Inhibitors, Exogenous,Channel Blockers, Calcium,Exogenous Calcium Blockader,Exogenous Calcium Inhibitor,Calcium Channel Antagonists,Calcium Channel Blocking Drugs,Exogenous Calcium Antagonists,Exogenous Calcium Blockaders,Exogenous Calcium Inhibitors,Antagonist, Calcium Channel,Antagonists, Calcium Channel,Antagonists, Exogenous Calcium,Blockader, Exogenous Calcium,Blocker, Calcium Channel,Blockers, Calcium Channel,Calcium Blockader, Exogenous,Calcium Inhibitor, Exogenous,Channel Antagonist, Calcium,Channel Blocker, Calcium,Inhibitor, Exogenous Calcium
D004910 Erythrocyte Membrane The semi-permeable outer structure of a red blood cell. It is known as a red cell 'ghost' after HEMOLYSIS. Erythrocyte Ghost,Red Cell Cytoskeleton,Red Cell Ghost,Erythrocyte Cytoskeleton,Cytoskeleton, Erythrocyte,Cytoskeleton, Red Cell,Erythrocyte Cytoskeletons,Erythrocyte Ghosts,Erythrocyte Membranes,Ghost, Erythrocyte,Ghost, Red Cell,Membrane, Erythrocyte,Red Cell Cytoskeletons,Red Cell Ghosts
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000252 Calcium-Transporting ATPases Cation-transporting proteins that utilize the energy of ATP hydrolysis for the transport of CALCIUM. They differ from CALCIUM CHANNELS which allow calcium to pass through a membrane without the use of energy. ATPase, Calcium,Adenosinetriphosphatase, Calcium,Ca(2+)-Transporting ATPase,Calcium ATPase,Calcium Adenosinetriphosphatase,Adenosine Triphosphatase, Calcium,Ca2+ ATPase,Calcium-ATPase,ATPase, Ca2+,ATPases, Calcium-Transporting,Calcium Adenosine Triphosphatase,Calcium Transporting ATPases,Triphosphatase, Calcium Adenosine
D017301 Ca(2+) Mg(2+)-ATPase An enzyme that catalyzes the hydrolysis of ATP and is activated by millimolar concentrations of either Ca(2+) or Mg(2+). Unlike CA(2+)-TRANSPORTING ATPASE it does not require the second divalent cation for its activity, and is not sensitive to orthovanadate. (Prog Biophys Mol Biol 1988;52(1):1). A subgroup of EC 3.6.1.3. ATPase, Calcium Magnesium,ATPase, Magnesium,Adenosinetriphosphatase, Calcium, Magnesium,Adenosinetriphosphatase, Magnesium,Calcium Magnesium ATPase,Calcium Magnesium Adenosinetriphosphatase,Magnesium ATPase,Magnesium Adenosinetriphosphatase,Adenosine Triphosphatase, Calcium, Magnesium,Adenosine Triphosphatase, Magnesium,Ca Mg-ATPase,Ca2+-Mg2+ ATPase,Calcium Magnesium Adenosine Triphosphatase,Mg2+-ATPase,Mg2+-Dependent ATPase,ATPase, Ca2+-Mg2+,ATPase, Mg2+-Dependent,Adenosinetriphosphatase, Calcium Magnesium,Ca Mg ATPase,Ca2+ Mg2+ ATPase,Magnesium Adenosine Triphosphatase,Mg2+ ATPase,Mg2+ Dependent ATPase

Related Publications

O O Olorunsogo, and O O Onatola, and S O Lawal, and E A Bababunmi, and A O Falase, and W G Okunade
Calmodulin antagonism and inhibition of erythrocyte plasma membrane Ca(2+)-pump by nifedipine, a calcium channel blocker.
October 1992, African journal of medicine and medical sciences,
O O Olorunsogo, and O O Onatola, and S O Lawal, and E A Bababunmi, and A O Falase, and W G Okunade
Erythrocyte membrane Ca2+-pumping ATPase of hypertensive humans: reduced stimulation by calmodulin.
June 1985, Bioscience reports,
O O Olorunsogo, and O O Onatola, and S O Lawal, and E A Bababunmi, and A O Falase, and W G Okunade
Does calmodulin mediate inhibition of human erythrocyte Ca(2+)-pumping ATPase by myricetin?
April 1991, Biochemical medicine and metabolic biology,
O O Olorunsogo, and O O Onatola, and S O Lawal, and E A Bababunmi, and A O Falase, and W G Okunade
Purification of a protein inhibitor of erythrocyte plasma membrane Ca(2+)-ATPase by Ca(2+)-ATPase-sepharose affinity chromatography.
May 1996, Biochemistry and molecular biology international,
O O Olorunsogo, and O O Onatola, and S O Lawal, and E A Bababunmi, and A O Falase, and W G Okunade
Erythrocyte membrane ATPase and calcium pumping activities in porcine malignant hyperthermia.
December 1987, Biochemical medicine and metabolic biology,
O O Olorunsogo, and O O Onatola, and S O Lawal, and E A Bababunmi, and A O Falase, and W G Okunade
Inhibition of Ca(2+) entry and suicidal erythrocyte death by naringin.
January 2012, Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology,
O O Olorunsogo, and O O Onatola, and S O Lawal, and E A Bababunmi, and A O Falase, and W G Okunade
Calcium entry-calcium refilling (CECR) coupling between store-operated Ca(2+) entry and sarco/endoplasmic reticulum Ca(2+)-ATPase.
March 2011, Cell calcium,
O O Olorunsogo, and O O Onatola, and S O Lawal, and E A Bababunmi, and A O Falase, and W G Okunade
Inhibition of plasma membrane Ca(2+)-ATPase by volatile anesthetics.
November 1996, Anesthesiology,
O O Olorunsogo, and O O Onatola, and S O Lawal, and E A Bababunmi, and A O Falase, and W G Okunade
Ca 2+ -activated membrane ATPase: selective inhibition by ruthenium red.
December 1971, Biochimica et biophysica acta,
O O Olorunsogo, and O O Onatola, and S O Lawal, and E A Bababunmi, and A O Falase, and W G Okunade
Inhibition of plasma membrane Ca(2+)-ATPase activity by volatile anesthetics.
October 1993, Anesthesiology,
Copied contents to your clipboard!